<DOC>
	<DOCNO>NCT01721928</DOCNO>
	<brief_summary>The main purpose NORIDES study investigate effect pharmacological thromboprophylaxis low molecular weight heparin ( LMWHs ) critically ill patient , affect presence acute kidney injury ( AKI ) treatment hemodialysis . The main objective compare prophylactic effect dalteparin intensive care unit ( ICU ) patient AKI Citrate-Calcium dialysis ( CiCa-dialysis ) control group ICU patient normal kidney function . Our main hypothesis CiCa-dialysis reduce dalteparin effect , patient undergo CiCa-dialysis achieve adequate prophylaxis venous thromboembolism ( VTE ) . The primary endpoint development DVT ICU stay , secondary endpoint inadequate heparin effect measure blood sample .</brief_summary>
	<brief_title>Norwegian Intensive Care Unit Dalteparin Effect Study</brief_title>
	<detailed_description>Description deep venous thrombosis ( DVT ) diagnosis : Screening DVT use Doppler Ultrasound ( DUS ) upper- low extremity perform within 48 hour ICU admission thereafter twice week discharge ICU ICU stay equal 30 day . An additional DUS perform 3 month ICU discharge . Description heparin effect measure blood sample : Blood sample draw intravasal catheter ( preferably arterial , alternatively central venous ) examine heparin effect ( anti-Xa activity , thrombin generation assay ( TGA ) thrombelastography ( TEG ) haematological analysis include antithrombin concentration . Whole blood drawn two separate day ( minimum day 2 maximum day 30 dependent dialysis therapy ) ICU stay immediately 4 hour dalteparin administration order measure tough peak effect heparin . Dalteparin effect ICU patient undergoing dialysis therapy measure one day one day without ongoing dialysis therapy order distinguish effect AKI effect continuous renal replacement therapy ( CRRT ) .</detailed_description>
	<mesh_term>Thrombosis</mesh_term>
	<mesh_term>Acute Kidney Injury</mesh_term>
	<mesh_term>Venous Thrombosis</mesh_term>
	<mesh_term>Dalteparin</mesh_term>
	<mesh_term>Heparin , Low-Molecular-Weight</mesh_term>
	<criteria>ICU patient receive prophylactic dalteparin Age &lt; 18 year Intraocular bleed Intracranial bleed Acute spinal cord lesion Inherited coagulopathy Ongoing , uncontrolled bleed Therapeutic anticoagulation Uncorrected coagulopathy Pregnancy postpartum &lt; 6 week Participation interventional study RIFLE class E Consent receive ICU length stay less 48 hour DVT detect first DUS examination</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>Acute kidney injury</keyword>
	<keyword>Deep venous thrombosis</keyword>
	<keyword>Dialysis</keyword>
	<keyword>Prophylaxis</keyword>
</DOC>